The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter
Completed
- Conditions
- Hyperthyreosis and GoiterThyroid Cancer
- Registration Number
- NCT01384786
- Lead Sponsor
- Copenhagen University Hospital at Herlev
- Brief Summary
Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated.
The investigators have found that thyroid cancer is not overlooked.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4474
Inclusion Criteria
- all patients treated with radioiodine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
herlev Hospital
🇩🇰Copenhagen, Denmark